| RS267606764 |
HOGA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS267606767 |
DHODH
|
Health Risk |
Pathogenic |
Miller syndrome, Miller syndrome |
| RS267606769 |
DHODH
|
Health Risk |
Pathogenic |
Miller syndrome, Miller syndrome |
| RS267606770 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS267606771 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS267606772 |
DNM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant Charcot-Marie-Tooth disease type 2M, Charcot-Marie-Tooth disease dominant intermediate B |
| RS267606773 |
DPYS
|
Health Risk |
Pathogenic |
Dihydropyrimidinase deficiency, Dihydropyrimidinase deficiency |
| RS267606774 |
DPYS
|
Health Risk |
Pathogenic |
Dihydropyrimidinase deficiency, Dihydropyrimidinase deficiency |
| RS267606775 |
DSG4
|
Health Risk |
Pathogenic |
Hypotrichosis 6, Hypotrichosis 6 |
| RS267606776 |
DSG4
|
Health Risk |
Pathogenic |
Hypotrichosis 6, Hypotrichosis 6 |
| RS267606777 |
DSG4
|
Health Risk |
Likely pathogenic |
Hypotrichosis 6, Hypotrichosis 6 |
| RS267606778 |
EDN3
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 4B, Waardenburg syndrome type 4B |
| RS267606779 |
EDN3
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 4B, Waardenburg syndrome type 4B |
| RS267606780 |
EDNRB
|
Health Risk |
risk factor |
Hirschsprung disease, susceptibility to |
| RS267606782 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, CARDIOMYOPATHY |
| RS267606783 |
ENG
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS267606784 |
ENPP1
|
Health Risk |
Pathogenic |
Arterial calcification, generalized |
| RS267606785 |
EPCAM
|
Health Risk |
Pathogenic |
Congenital diarrhea 5 with tufting enteropathy, Congenital diarrhea 5 with tufting enteropathy |
| RS267606786 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS267606787 |
F13A1
|
Health Risk |
Likely pathogenic |
Factor XIII, A subunit |
| RS267606788 |
F13A1
|
Health Risk |
Pathogenic |
Factor XIII, A subunit |
| RS267606789 |
F13A1
|
Health Risk |
Pathogenic |
Factor XIII, A subunit |
| RS267606790 |
F7
|
Health Risk |
Pathogenic |
Factor VII deficiency, Factor VII deficiency |
| RS267606791 |
F8
|
Health Risk |
Pathogenic |
Hereditary factor VIII deficiency disease, Thyroid cancer |
| RS267606792 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS267606793 |
FAM161A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 28, Retinitis pigmentosa 28 |
| RS267606794 |
FAM161A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 28, Retinal dystrophy |
| RS267606795 |
FAM20C
|
Health Risk |
Pathogenic |
Lethal osteosclerotic bone dysplasia, Lethal osteosclerotic bone dysplasia |
| RS267606796 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS267606797 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS267606798 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Stiff skin syndrome, Marfan syndrome |
| RS267606799 |
FBN1
|
Health Risk |
Pathogenic |
Stiff skin syndrome, Stiff skin syndrome |
| RS267606800 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Stiff skin syndrome, Marfan syndrome |
| RS267606801 |
FBN1
|
Health Risk |
Likely pathogenic |
Stiff skin syndrome, Marfan syndrome |
| RS267606802 |
FBN2
|
Health Risk |
Pathogenic |
Congenital contractural arachnodactyly, Congenital contractural arachnodactyly |
| RS267606805 |
FGFR1
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS267606806 |
FGFR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 2 with or without anosmia, Pfeiffer syndrome |
| RS267606811 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS267606812 |
FHL1
|
Health Risk |
Pathogenic |
Myopathy, reducing body |
| RS267606813 |
FHL1
|
Health Risk |
Pathogenic |
Myopathy, reducing body |
| RS267606814 |
FKTN
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS267606815 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac valvular dysplasia, X-linked |
| RS267606816 |
FLNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiac valvular dysplasia, X-linked |
| RS267606817 |
FLNA
|
Health Risk |
Pathogenic |
Cardiac valvular dysplasia, X-linked |
| RS267606818 |
FLT4
|
Health Risk |
Pathogenic |
Hereditary lymphedema type I, Hereditary lymphedema type I |
| RS267606819 |
FLVCR1
|
Health Risk |
Pathogenic |
Posterior column ataxia-retinitis pigmentosa syndrome, Posterior column ataxia-retinitis pigmentosa syndrome |
| RS267606820 |
FLVCR1
|
Health Risk |
Pathogenic |
Posterior column ataxia-retinitis pigmentosa syndrome, Posterior column ataxia-retinitis pigmentosa syndrome |
| RS267606821 |
FLVCR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Posterior column ataxia-retinitis pigmentosa syndrome, Inborn genetic diseases |
| RS267606822 |
FLVCR2
|
Health Risk |
Pathogenic |
Fowler syndrome, Fowler syndrome |
| RS267606823 |
FLVCR2
|
Health Risk |
Pathogenic |
Fowler syndrome, Fowler syndrome |
| RS267606824 |
FLVCR2
|
Health Risk |
Pathogenic |
Fowler syndrome, Fowler syndrome |
| RS267606825 |
FLVCR2
|
Health Risk |
Pathogenic |
Fowler syndrome, Fowler syndrome |
| RS267606826 |
FOXG1
|
Health Risk |
Pathogenic |
FOXG1 disorder, Inborn genetic diseases |
| RS267606827 |
FOXG1
|
Health Risk |
Pathogenic |
FOXG1 disorder, FOXG1 disorder |
| RS267606828 |
FOXG1
|
Health Risk |
Likely pathogenic |
FOXG1 disorder, FOXG1 disorder |
| RS267606829 |
FOXRED1
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 19 |
| RS267606830 |
FOXRED1
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 19 |
| RS267606832 |
FUS
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 6, Tremor |
| RS267606834 |
G6PC3
|
Health Risk |
Pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS267606837 |
GABRG2
|
Health Risk |
Pathogenic |
Febrile seizures, familial |
| RS267606838 |
GALNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS267606841 |
GALNT3
|
Health Risk |
Pathogenic |
Tumoral calcinosis, hyperphosphatemic |
| RS267606842 |
GDAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2K, Autosomal dominant Charcot-Marie-Tooth disease type 2K |
| RS267606843 |
GHSR
|
Health Risk |
Pathogenic |
Short stature due to growth hormone secretagogue receptor deficiency, Short stature due to growth hormone secretagogue receptor deficiency |
| RS267606844 |
GJA1
|
Health Risk |
Pathogenic |
Oculodentodigital dysplasia, autosomal recessive |
| RS267606845 |
GJA1
|
Health Risk |
Likely pathogenic |
Oculodentodigital dysplasia, autosomal recessive |
| RS267606846 |
GJC2
|
Health Risk |
Pathogenic |
Lymphatic malformation 3, Lymphatic malformation 3 |
| RS267606847 |
GJC2
|
Health Risk |
Pathogenic |
Lymphatic malformation 3, Lymphatic malformation 3 |
| RS267606848 |
GLRA1
|
Health Risk |
Pathogenic |
Hyperekplexia 1, Hyperekplexia 1 |
| RS267606849 |
GP1BA
|
Health Risk |
Pathogenic |
Bernard-Soulier syndrome, type A1 |
| RS267606850 |
GPC3
|
Health Risk |
Likely pathogenic |
Simpson-Golabi-Behmel syndrome type 1, Inborn genetic diseases |
| RS267606851 |
GPI
|
Health Risk |
Pathogenic |
Hemolytic anemia due to glucophosphate isomerase deficiency, Thyroid cancer |
| RS267606852 |
GPI
|
Health Risk |
Pathogenic |
Hemolytic anemia due to glucophosphate isomerase deficiency, Hemolytic anemia due to glucophosphate isomerase deficiency |
| RS267606853 |
GPI
|
Health Risk |
Pathogenic |
Hemolytic anemia due to glucophosphate isomerase deficiency, Hemolytic anemia due to glucophosphate isomerase deficiency |
| RS267606854 |
GPSM2
|
Health Risk |
Pathogenic |
Chudley-McCullough syndrome, Hearing loss |
| RS267606855 |
GRXCR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 25, Hearing loss |
| RS267606857 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Cone-rod dystrophy 6 |
| RS267606859 |
HADHB
|
Health Risk |
Pathogenic |
Mitochondrial trifunctional protein deficiency, Mitochondrial trifunctional protein deficiency 2 |
| RS267606861 |
HDC
|
Health Risk |
Pathogenic |
Tourette syndrome, Tourette syndrome |
| RS267606862 |
HEXA
|
Health Risk |
Pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS267606863 |
HPRT1
|
Health Risk |
Likely pathogenic |
Lesch-Nyhan syndrome, Lesch-Nyhan syndrome |
| RS267606864 |
HPSE2
|
Health Risk |
Pathogenic |
Urofacial syndrome type 1, Urofacial syndrome type 1 |
| RS267606865 |
HPSE2
|
Health Risk |
Pathogenic/Likely pathogenic |
Urofacial syndrome type 1, Congenital anomaly of kidney and urinary tract |
| RS267606866 |
HPSE2
|
Health Risk |
Pathogenic/Likely pathogenic |
Urofacial syndrome type 1, Urofacial syndrome type 1 |
| RS267606867 |
HRURF
|
Health Risk |
Pathogenic |
Hypotrichosis 4, Hypotrichosis 4 |
| RS267606868 |
HRURF
|
Health Risk |
Pathogenic |
Hypotrichosis 4, Hypotrichosis 4 |
| RS267606869 |
HRURF
|
Health Risk |
Pathogenic |
Hypotrichosis 4, Hypotrichosis 4 |
| RS267606870 |
IDH2
|
Health Risk |
Pathogenic |
D-2-hydroxyglutaric aciduria 2, D-2-hydroxyglutaric aciduria 2 |
| RS267606871 |
IGHM
|
Health Risk |
Pathogenic |
Autosomal recessive agammaglobulinemia 1, Autosomal recessive agammaglobulinemia 1 |
| RS267606872 |
IHH
|
Health Risk |
Pathogenic |
Brachydactyly type A1, Brachydactyly type A1 |
| RS267606873 |
IHH
|
Health Risk |
Likely pathogenic |
Brachydactyly type A1, Brachydactyly type A1 |
| RS267606874 |
IMPG2
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 56, Retinitis pigmentosa |
| RS267606875 |
IMPG2
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 56, Macular dystrophy |
| RS267606876 |
IMPG2
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 56, Retinal dystrophy |
| RS267606877 |
INF2
|
Health Risk |
Pathogenic |
Focal segmental glomerulosclerosis 5, INF2-related disorder |
| RS267606878 |
INF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS267606879 |
INF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS267606880 |
INF2
|
Health Risk |
Pathogenic |
Focal segmental glomerulosclerosis 5, Focal segmental glomerulosclerosis 5 |
| RS267606884 |
MT-CO1
|
Health Risk |
Pathogenic |
Familial colorectal cancer, Familial colorectal cancer |
| RS267606886 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |